Published in Exp Dermatol on February 01, 1994
Tissue granuloma structure-function in experimental visceral leishmaniasis. Int J Exp Pathol (2001) 1.67
Leishmania infection impairs beta 1-integrin function and chemokine receptor expression in mononuclear phagocytes. Infect Immun (2006) 0.92
The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis. Clin Exp Immunol (2009) 0.84
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med (1995) 2.30
A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med (1992) 1.93
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88
Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Immunol Immunopathol (1983) 1.87
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg (1972) 1.69
Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A (1988) 1.62
The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1993) 1.58
Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Clin Exp Immunol (1974) 1.54
Detection of antibodies toward secreted mycobacterial antigen 85 in untreated leprosy patients' sera. Int J Lepr Other Mycobact Dis (1999) 1.41
Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts. Int J Lepr Other Mycobact Dis (1982) 1.41
Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin Exp Immunol (1984) 1.40
[Clinical practice guidelines of the Spanish Society of Cardiology for pulmonary thromboembolism and hypertension]. Rev Esp Cardiol (2001) 1.39
Genetic organization of the catabolic plasmid pJP4 from Ralstonia eutropha JMP134 (pJP4) reveals mechanisms of adaptation to chloroaromatic pollutants and evolution of specialized chloroaromatic degradation pathways. Environ Microbiol (2004) 1.37
Activated suppressor T cells in leprosy. J Immunol (1982) 1.37
A test for the determination of competency in clearing bacilli in leprosy patients. Bull World Health Organ (1972) 1.34
Identification of the noncultivable pathogenic mycobacteria M. leprae and M. lepraemurium. Int J Lepr Other Mycobact Dis (1968) 1.33
Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity. Biochem J (1976) 1.33
High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis (2000) 1.30
Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. J Immunol (1989) 1.29
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. Clin Exp Immunol (1979) 1.26
ELECTRON MICROSCOPE STUDY OF MYCOBACTERIUM LEPRAE AND ITS ENVIRONMENT IN A VESICULAR LEPROUS LESION. J Bacteriol (1962) 1.25
Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J Clin Microbiol (1994) 1.24
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet (1987) 1.24
Studies on human polymorphonuclear leukocyte enzymes. I. Assay of acid hydrolases and other enzymes. Biochim Biophys Acta (1973) 1.21
Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res (1993) 1.20
Mycolic acids from "noncultivable" mycobacteria. Infect Immun (1974) 1.17
T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis. J Clin Microbiol (1988) 1.17
Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci U S A (1988) 1.15
Lymphocyte transformation with phytomitogens in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.15
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro. Biochem J (1975) 1.15
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol (1985) 1.13
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol (2007) 1.13
Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci U S A (1991) 1.12
Studies on human polymorphonuclear leukocyte enzymes. II. Comparative study of the physical properties of primary and specific granules. Biochim Biophys Acta (1973) 1.11
The surface membrane of Leishmania. I. The effects of lectins on different stages of Leishmania braziliensis. J Parasitol (1975) 1.09
Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol (2000) 1.05
Leprosy: confirmation in the armadillo. Science (1974) 1.05
Ethics of HIV trials. Lancet (1997) 1.04
Voriconazole in the treatment of invasive mold infections in transplant recipients. Eur J Clin Microbiol Infect Dis (2003) 1.03
IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Int J Lepr Other Mycobact Dis (1991) 1.02
Efficient degradation of 2,4,6-Trichlorophenol requires a set of catabolic genes related to tcp genes from Ralstonia eutropha JMP134(pJP4). Appl Environ Microbiol (2003) 1.00
Ectopic skin lesions produced by Schistosoma mansoni. Am J Trop Med Hyg (1973) 1.00
Studies on plating efficiency and estimation of viability of suspensions of Paracoccidioides brasiliensis yeast cells. Mycopathologia (1980) 1.00
Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production. Vaccine (1994) 0.98
Results of a double blind study of the influence of thalidomide on the lepra reaction. Int J Lepr Other Mycobact Dis (1970) 0.98
Characterization and properties of alpha-D-mannosidase of human polymorphonuclear leucocytes. Clin Chim Acta (1973) 0.96
Vaccination in leprosy--observations and interpretations. Int J Lepr Other Mycobact Dis (1980) 0.96
The Kellersberger Memorial Lecture: leprosy and leishmaniasis similar clinical-immunological-pathological models. Ethiop Med J (1974) 0.95
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol (2002) 0.95
Fabry's disease: normal alpha-galactosidase activity and urinary-sediment glycosphingolipid levels in two obligate heterozygotes. Br J Dermatol (1973) 0.93
Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol (2002) 0.93
A simple method for the differentiation of Mycobacterium leprae from other mycobacteria through routine staining technics. Int J Lepr Other Mycobact Dis (1973) 0.92
Delayed-type hypersensitivity and immunoglobulin E in American cutaneous leishmaniasis. Infect Immun (1982) 0.91
The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr Rev (1986) 0.91
Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela). Trans R Soc Trop Med Hyg (2000) 0.90
Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients. Parasite Immunol (2000) 0.90
Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57BL/6 mice. Am J Trop Med Hyg (1990) 0.90
Specificity of the 48-hour reaction to Mitsuda antigen. Use of a soluble antigen from human and armadillo lepromin. Bull World Health Organ (1975) 0.90
Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy. Clin Exp Immunol (1995) 0.90
Defect of in vitro digestive ability of polymorphonuclear leukocytes in paracoccidioidomycosis. Infect Immun (1980) 0.88
Some considerations regarding the immunology of leprosy. Int J Lepr Other Mycobact Dis (1972) 0.88
Serological and immunohistological studies on lepromatous leprosy. Int Arch Allergy Appl Immunol (1981) 0.88
The effect of fresh serum on the leptomonads of Leishmania. I. Preliminary report. Trans R Soc Trop Med Hyg (1968) 0.88
Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop (1991) 0.87
Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers. Eur J Clin Microbiol Infect Dis (2011) 0.87
Heterogeneity of acid phosphatase activity in human polymorphonuclear leukocytes. Clin Chim Acta (1973) 0.87
Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. Vaccine (1994) 0.87
Cyclic changes of the ovarian surface epithelium in the rat. Reproduction (2005) 0.86
Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis. Immunol Today (1994) 0.85
Leishmania braziliensis causing visceral leishmaniasis in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg (1994) 0.85
Recent advances in the immunology of leprosy. Int J Dermatol (1976) 0.85
Polymorphonuclear activation in leprosy. I. Spontaneous and endotoxin-stimulated reduction of nitroblue tetrazolium: effects of serum and plasma on endotoxin-induced activation. Clin Exp Immunol (1975) 0.85
Immunological reactions in onchocerciasis. Trans R Soc Trop Med Hyg (1970) 0.85
Spheroidal bodies and globi of human leprosy. Biochem Biophys Res Commun (1973) 0.84
A study of antibody response in leprosy. Int J Lepr Other Mycobact Dis (1969) 0.84
Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela. Mem Inst Oswaldo Cruz (2004) 0.84
Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population. Tissue Antigens (1984) 0.84
Leukocyte immunophenotypes in bronchoalveolar lavage fluid and peripheral blood of paracoccidioidomycosis, sarcoidosis and silicosis. Histol Histopathol (1991) 0.83
Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy. Parasite Immunol (1989) 0.83
Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo. Histol Histopathol (1987) 0.82
Applying the indirect immunofluorescency test to the study of American cutaneous leishmaniasis. Dermatol Int (1969) 0.82
Immunotherapy and immunoprophylaxis of leprosy. Lepr Rev (1983) 0.82
Isolation of Leishmania infantum, zymodeme MON-1 from canine and human visceral leishmaniasis on Margarita Island, Venezuela. Mem Inst Oswaldo Cruz (2001) 0.82
Epithelioid malignant peripheral nerve sheath tumour in a dog. J Comp Pathol (2004) 0.82
The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production. Biol Res (1993) 0.82
Loss of lineage antigens is a common feature of apoptotic lymphocytes. J Leukoc Biol (2004) 0.81
Control of paratuberculosis (Johne's disease) in goats by vaccination of adult animals. Vet Rec (2000) 0.81
Histochemical identification of non-culturable mycobacteria (M. leprae and M. lepramurium). II. Dopa-oxidase. Histochemie (1973) 0.81